Results from this cohort study showed that biologics were much more effective than conventional synthetic drugs as primary therapy. Patients with adult-onset Still's disease were much more likely ...

The three types of DMARDs are biologic, conventional, and targeted synthetic DMARDs. These all have the aim of slowing down PsA to save the joints. They do it by reducing inflammation and ...

Although these approaches are adequate for simple genetic manipulations, such as introducing small expression cassettes, they have several limitations for more sophisticated synthetic biology ...

The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) than in patients who ...

Bionic Biologics represent a novel therapeutic modality that integrates principles of biologic and synthetic design. This innovative platform enables the targeting of well-validated yet previously ...

Biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) seemed to be the most effective treatments for patients with acute psoriatic arthritis (PsA) dactylitis. In a ...